Imbalanced Expression of Inhibin and Activin Subunits in Primary Epithelial Ovarian Cancer

By Zheng W.   Luo M.P.   Welt C.   Lambert-Messerlian G.   Sung C.J.   Zhang Z.   Ying S.-y.   Schneyer A.L.   Lauchlan S.C.   Felix J.C.  

Gynecologic Oncology, Vol. 69, Iss. 1, 1998-04 ,pp. : 23-31

Elsevier

Access to resources Recommend Favorite

Serum Inhibin and Disease Status in Women with Ovarian Granulosa Cell Tumors

By Boggess J.F.   Soules M.R.   Goff B.A.   Greer B.E.   Cain J.M.   Tamimi H.K.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 64-69

Elsevier

Access to resources Recommend Favorite

The Effect of Raloxifene on the Incidence of Ovarian Cancer in Postmenopausal Women

By Neven P.   Goldstein S.R.   Ciaccia A.V.   Zhou L.   Silfen S.L.   Muram D.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 388-390

Academic Press

Access to resources Recommend Favorite

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

By Chen Hongmin   Wang Li   Beretov Julia   Hao Jingli   Xiao Weiwei   Li Yong  

Clinical and Experimental Metastasis, Vol. 27, Iss. 8, 2010-12 ,pp. : 557-569

Springer Publishing Company

Access to resources Recommend Favorite

Serum HE4 levels combined with CE CT imaging improve the management of monitoring women affected by epithelial ovarian cancer

By                  

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2481-2487

Spandidos Publications

Access to resources Recommend Favorite